Pharmaceutical Institute has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute’s already extensive library of training resources.

Pharmaceutical Institute is a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance. Financial terms of the agreement were not disclosed.

As part of the agreement, Pharmaceutical Institute acquired 155 e-courses, including:

— 135 e-courses in key therapeutic areas, including cardiovascular,
diabetes, respiratory, gastrointestinal, muscular skeletal, kidney,
infection, oncology, central nervous system, pain and anesthesia,
urinary, and metabolism.

— 12 e-courses in biopharmaceutical technology, including human gene
therapy, genomics, combinatorial chemistry, computer-assisted drug
design, immunity and disease, bioinformatics, advanced bioinformatics,
microarrays, SNPs, methods in microbiology, and microarray
informatics.

— 8 e-courses in clinical trial regulation, including biostatistics,
adverse events reporting, good clinical practices, good laboratory
practices, and 21 CFR part 11 (electronic records and signatures).

Related Health News:

1. Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson CAMBRIDGE, Mass., April 14 /PRNewswire/ — Gene Network Sciences, Inc. (GNS) today announced that it has entered into a research collaboration with The University of...
2. Gyrodyne Acquires Fairfax Medical Center in Fairfax, Virginia Gyrodyne Company of America Inc. has acquired the Fairfax Medical Center in Fairfax, Virginia for $12,891,000, or $221.84 per square foot. The acquisition represents...
3. New CenterWatch Report Examines Japan’s Surging Clinical Trials Market CenterWatch releases new report examining Japan’s clinical trials market, the differences in the country’s approach to clinical research, and new government initiatives aimed at...
4. Medical Provider Class Action Certified against Safeco An Illinois Circuit Court certified a class action case against Safeco Insurance Company of America and Safeco Insurance Company of Illinois. The case covers medical...
5. Clinical Trials of the America’s Inc. Enters into Binding Letter of Intent with Next Fuels, Inc. CAREY, N.C., April 8 /PRNewswire-FirstCall/ — Clinical Trials of America Inc. (“Clinical Trials” of the “Company”) (OTC:CLLL) (BULLETIN BOARD: CLLL) announced that it has entered...